Oxyglobin solution for infusion [hemoglobin glutamer - 200 (bovine)] is the first and only oxygen therapeutic to receive approvals from both the US FDA and the European Commission, for veterinary use. The product is indicated for the treatment of all-cause canine anemia, a potentially life-threatening condition that affects millions of dogs globally each year. Oxyglobin was introduced to US veterinarians in 1998, and to Europe in 1999.

Oxygen is carried in the hemoglobin of red blood cells, and anemia occurs when there is a reduction in the number of circulating red blood cells in a dog’s body. Anemia  could result  from the dog’s body destroying its own red blood cells, active bleeding that results in a loss of blood volume, or  the inability for a dog’s body to produce new red blood cells.  Other than a blood transfusion, Oxyglobin is the only approved treatment that provides immediate relief from the clinical signs of anemia in dogs. The product does not cure a disease state. It provides temporary metabolic support  necessary while the patient is treated for the cause of the anemia.


Oxyglobin is room temperature stable for a minimum of three years. Oxyglobin is administered intravenously, and can be given to a dog with any blood type. There is no typing or crossmatch required, no reconstitution, and the product can be infused using a standard infusion set. 


Due to our manufacturing facility being shut down and in the midst of an expansion, Oxyglobin is not currently available.


For the US package insert, please click here.


For the European Medicines Agency product information, page, please click here.

© 2020  Hemoglobin Oxygen Therapeutics LLC